NCT07246187
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
Registry fields
- Overall status
- COMPLETED
- Conditions
- Cannabinoid Hyperemesis Syndrome
- Study type
- INTERVENTIONAL
- Phase
- PHASE3
- Primary purpose
- TREATMENT
- Intervention type
- DRUG
- Interventions
- Olanzapine 10 milligram, Haloperidol
- Lead sponsor
- Mercy Bon Secours Saint Vincent Medical Center (OTHER)
Cached at: 2026-10-24 00:03:12
Brief summary
The aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabinoid hyperemesis using a 10-point visual analog scale with intervals of 0.5.
Contact
Need a report or Korean medical writing based on this trial?
Sign in with Kakao to continue